Three collaborative papers just came out recently after two years' lab opening in IBMS at Academia Sinica. I am glad that my lab has contributed to being part of it! We have excitingly identified the first DUB, which can modulate PD1 stability and subsequently contributes to modulating cancer immunotherapy. Additionally, we also identified two novel post-translational modifications of RIPK1 to control its biological functions under different physiological conditions. Big congrats to Dr. Jinfang Zhang and Dr. Wenyi Wei!!
https://www.science.org/doi/10.1126/science.abn1725?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
https://www.nature.com/articles/s41556-023-01170-4
https://www.nature.com/articles/s41467-023-38605-3